From the Dollars for Docs database at ProPublica one of the top pharma paid psychiatrists is Dr. Jon Draud.
Payment Records
Total Received
$200,075
Payments Received At
Nashville, Tenn.
Records used to add up the total payments for Jon W. Draud
Eli Lilly
2009 Q1-Q4 $74,850
Payee
DRAUD, JON WINSTON
Listed Name
DRAUD, JON WINSTON
City
NASHVILLE
State
TN
Number of activities 43
Healthcare Professional Education Programs 65475.00
Advising/Consulting and International Education Programs 9375.00
Total 74850.00
Eli Lilly
2010 Q1 $46,809
Eli Lilly has since updated its 2010 report, so this healthcare provider's amount may have changed.
Payee
DRAUD, JON W
Listed Name
DRAUD, JON W
City
NASHVILLE
State
TN
Healthcare Professional Education Programs 38450.00
Advising/Consulting and International Education Programs 7000.00
Certain Travel Related Expenses 1359.00
Total 46809.00
AstraZeneca
2010 Q1-Q2 $45,000
Payee
JON DRAUD
Listed Name
Draud, Jon
City
Nashville
State
TN
amount 45000.00
Pfizer
2009 Q3-Q4 $16,566
Payee
DRAUD, JON WINSTON
Listed Name
DRAUD, JON WINSTON
City
NASHVILLE
State
TN
Service/Activity Expert-Led Forums
Cash 15450.00
Role Healthcare Professional
Service/Activity Meals
Non-cash 139.00
Role Healthcare Professional
Service/Activity Business Related Travel
Non-cash 977.00
Role Healthcare Professional
Cephalon
2009 Q1-Q4 $9,050
Payee
Listed Name
Draud, Jon W
City
Nashville
State
TN
title MD
Amount 9050.00
Description Honoraria
Cephalon
2010 Q1-Q2 $7,800
Cephalon has since updated its 2010 report, so this healthcare provider's amount may have changed.
Payee
Listed Name
Draud, Jon W
City
Nashville
State
TN
title MD
Amount 7800.00
Description Honoraria
----
Jon W. Draud is a moderator of CME (Continuing Medical Education)courses, at CME-Treating the Whole Patient.
Draud will be 'faculty' for Mental Health Regional Series for doctors to learn and gain credits. With that kind of pharma income lining his pockets would you want him teaching your doctor about Treatment Resistant Depression? I wonder which drug he'll promote for that.
---
What will happen to doctors like Draud and the CME courses moderated by him and others considering the AMA just proposed no industry ties for CME?
The pdf report:
RECOMMENDATION
"The Council on Ethical and Judicial Affairs recommends that the following be adopted and the remainder of this report be filed: In an environment of rapidly changing information and emerging technology, physicians must maintain the knowledge, skills, and values central to a healing profession. They must protect the independence and commitment to fidelity and service that define the medical profession. Financial or in-kind support from pharmaceutical, biotechnology or medical device companies that have a direct interest in physicians’ recommendations creates conditions in which external interests could influence the availability and/or content of continuing medical education (CME). Financial relationships between such sources and individual physicians who organize CME, teach in CME, or have other roles in continuing professional education can carry similar potential to influence CME in undesired ways. CME that is independent of funding or in-kind support from sources that have financial interests in physicians’ recommendations promotes confidence in the independence and integrity of professional education, as does CME in which organizers, teachers, and others involved in educating physicians do not have financial relationships with industry that could influence their participation. When possible, CME should be provided without such support or the participation of individuals who have financial interests in the educational subject matter.
In some circumstances, support from industry or participation by individuals who have financial interests in the subject matter may be needed to enable access to appropriate, high-quality CME. In these circumstances, physician-learners should be confident that that vigorous efforts will be made to maintain the independence and integrity of educational activities. Individually and collectively physicians must ensure that the profession independently defines the goals of physician education, determines educational needs, and sets its own priorities for CME.
Physicians who attend CME activities should expect that, in addition to complying with all applicable professional standards for accreditation and certification, their colleagues who organize, teach, or have other roles in CME will:
a) be transparent about financial relationships that could potentially influence educational activities. (b) provide the information physician-learners need to make critical judgments about an educational activity, including: (i) the source(s) and nature of commercial support for the activity; and/or (ii) the source(s) and nature of any individual financial relationships with industry related to the subject matter of the activity; and (iii) what steps have been taken to mitigate the potential influence of financial relationships. (c) protect the independence of educational activities by:(i) ensuring independent, prospective assessment of educational needs and priorities; (ii) adhering to a transparent process for prospectively determining when industry support is needed; (iii) giving preference in selecting faculty or content developers to similarly qualified experts who do not have financial interests in the educational subject matter; (iv) ensuring a transparent process for making decisions about participation by physicians who may have a financial interest in the educational subject matter; (v) permitting individuals who have a substantial financial interest in the educational subject matter to participate in CME only when their participation is central to the success of the educational activity; the activity meets a demonstrated need in the professional community; and the source, nature, and magnitude of the individual’s specific financial interest is disclosed; and (vi) taking steps to mitigate potential influence commensurate with the nature of the financial interest(s) at issue, such as prospective peer review."
Report via retired PSYCHIATRIST, and author of 1 Boring Old Man blog calls this "a start".
Something tells me that doctors with income from pharma such as Dr.Draud might have the most difficult time adjusting to new rules. After all, the most provocative proposal of all would be to completely ban pharmaceutical companies from forking out money to any person, institution, hospital, learning campus, CME course providers, nurses, and doctors, researchers, trial studies....eliminate the pharmaceutical industry from our healthcare and we might finally begin to become healthy as a nation and a population. No need for disease-mongering or creating illness with patent extender drugs such as Seroquel, Effexor and Risperdal--Zyprexa, Prozac, Cymbalta--pain, depression, bipolar, schizophrenia, insomnia...the list goes on and on how these drugs are re-marketed for use, often with adjusted names and labels, and the product keeps on trucking bank for pharma companies.
America does not have a mental illness crisis, America has a pharmaceutical industry take over crisis, and it's time to get back to the root of the problem, and that is not for people to explore their life situations from the bottom of a pill bottle.
Subscribe to:
Post Comments (Atom)
Posts
0 comments:
Post a Comment